The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Potassium Phosphates
Potassium Phosphates · MONOBASIC POTASSIUM PHOSPHATE 11.2 mg/mL; DIBASIC POTASSIUM PHOSPHATE 11.8 mg/mL · Injection, Solution · Intravenous · Fresenius Kabi USA, LLC
NDC 65219-0656-10 · 24 POUCH in 1 CARTON / 1 BAG in 1 POUCH / 100 mL in 1 BAG · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$912.00
Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 2 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program · Xywav and Xyrem
Regulatory
- Application
- NDA212832
- TE code
- AP
- Approval date
- Nov 26, 2019
- Patents / exclusivity
- 4 patents, 0 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| patent | 11925661 | Oct 12, 2041 |
| patent | 11925661 | Oct 12, 2041 |
| patent | 11813291 | Oct 12, 2041 |
| patent | 11813291 | Oct 12, 2041 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Potassium Phosphates (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| American Regent, Inc. | POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 4.48 mg/mL; DIBASIC POTASSIUM PHOSPHATE 4.72 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 11.2 mg/mL; DIBASIC POTASSIUM PHOSPHATE 11.8 mg/mL | Aug 26, 2026 | Sep 2, 2026 |
| American Regent, Inc. | POTASSIUM PHOSPHATE, MONOBASIC 236 mg/mL; POTASSIUM PHOSPHATE, DIBASIC 224 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 11.8 mg/mL; DIBASIC POTASSIUM PHOSPHATE 11.2 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| Fresenius Kabi USA, LLC | MONOBASIC POTASSIUM PHOSPHATE 4.72 mg/mL; DIBASIC POTASSIUM PHOSPHATE 4.48 mg/mL | Jul 22, 2026 | Aug 19, 2026 |
| American Regent, Inc. | POTASSIUM PHOSPHATE, DIBASIC 236 mg/mL; POTASSIUM PHOSPHATE, MONOBASIC 224 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
| Fresenius Kabi USA, LLC | DIBASIC POTASSIUM PHOSPHATE 4.72 mg/mL; MONOBASIC POTASSIUM PHOSPHATE 4.48 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
| Fresenius Kabi USA, LLC | DIBASIC POTASSIUM PHOSPHATE 11.8 mg/mL; MONOBASIC POTASSIUM PHOSPHATE 11.2 mg/mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Potassium Phosphates — NDC 65219-0656-10," retrieved September 3, 2026, https://drugdashboards.com/drug/65219065610.
Free to cite with attribution — see how the data is put together.